NCT06644989

Brief Summary

One way for runners to improve their performance and remain injury free is to preserve and improve joint mobility, especially at the hips. The femoroacetabular joints are a pivotal part of the running gait allowing the athlete to fully extend their leg to generate sufficient force in each stride. Improving hip range of motion can help reduce or prevent groin pain, make the runner more comfortable while running, improve running longevity, and prevent injuries. Thus, it is clear that a runner's commitment to improving the range of motion of their hips is crucial for both the enhancement of their performance and prevention of injury. Researchers assessed how the hip, and its biomechanics, can be impacted by Osteopathic medical treatment. The primary research question investigated is how Spencer Technique for the hip impacts femoral acetabular active range of motion (AROM) in flexion, extension, abduction, adduction, internal rotation, and external rotation in those training 4 weeks for a 5K race. This study investigated the effect that 4 weeks of twice weekly, bilateral, Spencer Technique treatment had on femoroacetabular range of motion. During this 4-week period participant exercise and stretching habits in preparation for the 5k race were recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 14, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 16, 2024

Completed
Last Updated

October 24, 2024

Status Verified

October 1, 2024

Enrollment Period

2 months

First QC Date

October 14, 2024

Last Update Submit

October 22, 2024

Conditions

Keywords

Osteopathic Manipulative TherapySpencer Technique

Outcome Measures

Primary Outcomes (1)

  • Range of Motion

    Hip range of motion (flexibility) is measured to monitor changes in flexibility

    4 weeks

Study Arms (2)

Sham Comparator

SHAM COMPARATOR

Half of Participants receive Spencer technique and half of participants received a sham treatment.

Other: Sham (No Treatment)

Experimental

EXPERIMENTAL

Half of Participants receive Spencer technique and half of participants received a sham treatment.

Procedure: Spencer Technique

Interventions

Spencer technique on the hip

Experimental

Spencer technique position but no pressure

Sham Comparator

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All LECOM-Bradenton students will be included in recruitment.

You may not qualify if:

  • Subjects will be excluded from this research study if they cannot sign an informed consent. Additionally, subjects will be excluded if they are:
  • Pregnant or plan to become pregnant
  • Have a past medical history including:
  • Skin disorders or open wounds precluding skin contact
  • Neurological symptoms (i.e. numbness, tingling, weakness)
  • Recent bone fracture
  • Recent lower extremity ligamentous sprain
  • Recent lower extremity muscle strain
  • Adhesive capsulitis of the hip joint
  • Osteoarthritis of the lower extremity
  • Rheumatoid arthritis
  • History of hip or knee arthroplasty
  • year history of any lower extremity surgery
  • Gout
  • Iliotibial band syndrome
  • +17 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LECOM

Bradenton, Florida, 34211, United States

Location

MeSH Terms

Interventions

salicylhydroxamic acid

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Single blinded study
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Biochemistry and Genetics

Study Record Dates

First Submitted

October 14, 2024

First Posted

October 16, 2024

Study Start

January 1, 2024

Primary Completion

February 29, 2024

Study Completion

February 29, 2024

Last Updated

October 24, 2024

Record last verified: 2024-10

Locations